Screen Drug Test Surfaces And Dust

Instructions for use for each combination of tests to test any combination of the following drugs: Cocaine, Marijuana/THC, Methamphetamine, Amphetamine, Ketamine, MDMA/Ecstasy, Morphine.

PRECAUTIONS
• Product not intended for diagnostic use.
• Do not use beyond the expiry date.
• Store the test in the closed pouch until ready for use.
• All samples must be considered potentially dangerous and therefore must be handled with the precautions for use relating to potentially infectious products.
• After use, the panel must be disposed of according to local regulations in force.
Store in the packaging at a temperature between 2°. and 30°C.
The test is stable until the expiration date indicated on the package label.
The test must be stored in the closed package until used.
Do not freeze.
Do not use beyond the expiry date.

INTENDED USE AND SUMMARY
Rapid chromatographic immunological test for the qualitative identification of multiple drugs and metabolites on surfaces and solids at the following threshold concentrations:

Test	Calibrator	Threshold-limit (ng/mL)
Amphetamine (AMP)	D-Amphetamine	1,000
Cocaine (COC)	Benzoylecgonine	300
Marijuana (THC)	11-nor-Δ9-THC-9 COOH < /td>	50
Methamphetamine (MET)	D-Methamphetamine	1,000
Methylenedioxymethamphetamine (MDMA)	D,L-Methylenedioxymethamphetamine	500
Morphine (MOP)< /td>	Morphine	300
Ketamine (KET)	Ketamine	1,000< /td>

Product not intended for medical diagnostic use.
This test provides only a preliminary analytical result.
It will be It is necessary to use a more suitable alternative chemical method. specific to obtain a confirmatory analytical result.
Medical judgment and professional advice will be necessary to evaluate any test for drugs of abuse, particularly when these indicate preliminary positive results.

SUMMARY
The rapid test Screen Drug Test is a rapid test of surfaces or solids that can be performed without the use of instruments.
The test uses monoclonal antibodies to selectively detect high levels of specific drugs on surfaces and solids.

Amphetamine (AMP)
Amphetamine is a substance classified in Schedule II of the US DEA sold by prescription (Dexedrine) and also available illegally on the market. Amphetamines are a class of potent sympathomimetic agents with therapeutic functions. They are chemically linked to two catecholamines produced naturally by the human body: epinephrine and norepinephrine. High acute doses induce stimulation of the central nervous system and cause euphoria, clarity, decreased appetite and a sense of greater energy and power. Cardiovascular reactions to amphetamines include increased blood pressure and cardiac arrhythmias. More reactions acute cases cause anxiety, paranoia, hallucinations and psychotic behavior.

Cocaine (COC)
Cocaine is a powerful central nervous system stimulant and a local anesthetic. Initially it causes extreme energy and restlessness which however gradually becomes tremor, hypersensitivity and and spasms.
Cocaine, taken in high doses, causes fever, loss of sensation, difficulty speaking. respiratory and loss of consciousness.
Cocaine is often self-administered by nasal inhalation, intravenous injection and smoking in free base.

Marijuana (THC)
THC (Δ9-tetrahydrocannabinol) and the main active ingredient of cannabis (marijuana).
When smoked or administered orally, THC produces euphoria.
Those who use it experience damage to short-term memory and slow learning.
You may also experience transient episodes of confusion and anxiety.
Relatively heavy and long-term use can cause damage. be associated with behavioral disorders.
The peak effect of smoking marijuana occurs within 20-30 minutes and the duration is 90-120 minutes after a cigarette.

Methamphetamine (MET)
Methamphetamine is a stimulant drug that energetically activates certain brain systems.
Methamphetamine is chemically very similar to Amphetamine, but its effects on the central nervous system are greater.
Methamphetamine is produced in illegal laboratories and has a high potential for abuse and addiction.
Drugs can cause It can be taken orally, injected, or inhaled.
High acute doses induce excessive central nervous system stimulation, euphoria, alertness, reduced appetite, and a sense of increased energy and potency.
Cardiovascular reactions to Methamphetamine include increased blood pressure and cardiac arrhythmias.
More reactions acute cases cause anxiety, paranoia, hallucinations, psychotic behavior and ultimately depression and fatigue.

Ecstasy (MDMA)
MethylenedioxyMetamphetamine (ecstasy) is a a synthetic drug first synthesized in 1914 by a company German pharmaceutical for the treatment of obesity.
Those who take it frequently have experienced side effects, such as increased muscle tension and sweating.
MDMA is not clearly a stimulant, even if it shares the ability to to increase blood pressure and heart rate.
MDMA produces some changes in perception by increasing sensitivity to in the light, difficulty of concentration and blurred vision in some subjects. Its mechanism of action is thought to occur via the neurotransmitter serotonin.
MDMA can also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990).
The main effect of MDMA, which is likely to occur in anyone who has taken a reasonable dose, is to produce a contraction of the jaws.

Morphine (MOP)
The term Opiate refers to any substance derived from the opium poppy, including natural products, morphine, codeine and semi-synthetic drugs such as heroin.
The term Opioid is more generic and refers to any drug that acts as an opioid receptor.
Opioid analgesics include a large group of substances that control pain by sedating the central nervous system.
High doses of Morphine can produce high levels of tolerance, physiological dependence and can lead to abuse of the substance.
Morphine is eliminated without being metabolised and is also the main metabolic product of codeine and heroin.

Ketamine (KET)
Ketamine is a dissociative anesthetic developed in 1963 to replace PCP (Phencyclidine).
While Ketamine is still used in human and veterinary anesthesia, it is increasingly being used abused as a drug.
Ketamine is molecularly similar to PCP and therefore creates similar effects including numbness, loss of coordination, sense of invulnerability, stiffness and muscle, aggressive/violent behavior, slurred speech or aphasia, exaggerated sense of strength and blank stare.
Presents a depression of respiratory function but not of the central nervous system and cardiovascular function is maintained.

PRINCIPLE
During the test the sample migrates upwards by capillary action.
A drug, if present in the sample below the threshold concentration, will not saturate the sample. the binding sites of this specific antibody.
The antibody will therefore react with the drug-protein conjugate and will appear a colored line visible in the test region for the specific drug tested.
The presence of the drug above the threshold concentration will saturate the drug. all antibody binding sites.
Therefore the colored line will not form in the test area.
A positive sample will not generate a colored line in the specific test area of the strip due to drug competition, while a drug-negative sample will generate a a line in the test area for the absence of competition.
For procedural control purposes, a line will appear always a colored line in the control area, indicating that it is a correct volume of sample has been poured and that the membrane is been soaked.

REAGENTS
Each test line contains a guinea pig monoclonal anti-drug antibody and the related drug-protein conjugates.
The control line contains polyclonal anti-rabbit goat IgG and rabbit IgG antibodies.

PRECAUTIONS
• Disposable.
• Do not touch the extremities free the strips to avoid contamination.
• Do not immerse the holder beyond the maximum level indicated.
• Dip the test into the buffer until one or two red lines appear in the reaction zone (~15 seconds).
• Do not pour samples into the reaction zone.
• Samples may be potentially infectious. Establish appropriate disposal and handling methods.
• Do not use the Multi Drug device beyond the expiration date.
• Do not use the test if the packaging is damaged.
• Use the test immediately after opening it.
• Please take into account specificities and cross reactivity for evaluation.
• Always store and transport the test device at 2-30°C.

STORAGE AND STABILITY
Store in the original sealed packaging at 2-30°C.
The test is stable until the expiry date printed on the package.
The test must remain in the sealed package until used.
Do not freeze.
Do not use beyond the expiry date.

MATERIALS SUPPLIED
• Device.
• Information leaflet.
• Buffer.

MATERIALS REQUIRED BUT NOT PROVIDED
• Sample collection container.
• Timer.

INSTRUCTIONS FOR USE
The test device (in sealed packages), samples and controls should be brought to room temperature (15-30°C) before the test.
Do not open packages until it was not ready to carry out the test.

FOR SURFACES
1. Pass the strips over the surface to be analysed.
2. Remove the cappuccino from the bottle provided.
3. Pour all the buffer from the bottle into the protective lid.
4. Insert the Multi Test slowly and carefully into the lid with the buffer.
5. Wait for the lines to appear on the membrane and read the results after 5 minutes. Do not interpret the results after 10 minutes.

FOR SOLIDS
1. Open the bottle and insert the solid into the buffer.
2. Close the bottle with the dropper and cap . Shake it briefly. Wait 30 seconds.
3. Remove the cappuccino from the bottle;.
4. Pour all the buffer with the dissolved substances into the protective cover.
5. Insert the Multi Test slowly and carefully into the protective cover with the buffer.
6. Wait for the lines to appear on the membrane and read the results after 5 minutes. Do not interpret the results after 10 minutes.

INTERPRETATION OF RESULTS
Negative*: a colored line appears in the Control area (C) and a colored line in the Test area ( T). This negative result indicates that the concentrations in the sample are below the threshold levels established for a particular drug tested.
*the shade is of the colored line(s) in the test area (T) may to vary. The result must be considered negative whenever even a faint line appears. Positive: a colored line appears in the Control area (C) and no line appears in the Test area (T). The positive result indicates that the concentration of the drug in the sample is greater than the limit threshold established for a specific drug.
Null: no line appears in the control area (C). The most important reasons Insufficient sample volume or incorrect procedural techniques are likely to cause a missing Control line. Read the instructions again and repeat the test. If the result is still null, contact the manufacturer.

QUALITY CONTROL
In the test it is including a procedural check.
The line that appears in the control area (C) is considered an internal procedural control.
Confirms that it is a sufficient volume of sample, adequate membrane imbibition and correct procedural technique were used.
Control standards are not provided with this kit.
However, testing positive and negative controls is recommended as good laboratory practice to confirm the test procedure and its correct functioning.

LIMITATIONS
1. The Rapid Screen Drug Test provides only a preliminary qualitative analytical result. &` It is necessary to use a secondary analytical method to confirm the result. The recommended confirmation method is gas chromatography/mass spectrometry (GC/MS).
2. A negative result may not necessarily indicate a drug-free sample. &` It is possible to get negative results when the drug is present below the test limit threshold.
3. This test does not distinguish between drugs of abuse and some drugs.

EXPECTED VALUES
The negative result indicates that the concentration of the drug is below the level of detection.
A positive result indicates that the concentration of the drug is above the detection level.

FORMAT
• 1 bottle.
• 1 Drug Test Surfaces Dust.
• 1 leaflet.